MEDIBIOFARMA
MediBioPharma is a clinical-stage biotechnology company which is fcused on drug discovery.
MEDIBIOFARMA
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Website Url:
http://www.medibiofarma.com
Status:
Active
Total Funding:
1.46 M USD
Similar Organizations
Calidi Biotherapeutics
Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Investors List
Official Site Inspections
http://www.medibiofarma.com
- Host name: d297.dinaserver.com
- IP address: 82.98.134.184
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "MediBiofarma"
Medibiofarma - Biotechnology Company
Medibiofarma discovers and develops new chemical entities (NCEs) with clinical proof-of-concept data in human patients. Medibiofarma focuses internal resources in the followings areas: Drug …See details»
About US - Medibiofarma
Medibiofarma is a Spanish biotechnology company founded by a group of professionals with extensive experience in Drug Discovery in pharmaceutical industry. The company´s aim is generating high quality pharmaceutical …See details»
Investors - Medibiofarma
Investors - In 2018 Medibiofarma has applied for a public grant offered by Government of Navarre to support R & D projects, to execute the project “Discovery of new PPAR-receptor receptor antagonists for the treatment of …See details»
MediBiofarma - Crunchbase Company Profile & Funding
Medibiofarma is a biotechnology company. Medibiofarma provides small molecule drugs for the treatment of cancer, activation of the immune system, treatment of non-cancer diseases, and target related diseases. They also provide drugs for …See details»
Medibiofarma SL - Navarra Health Cluster
MEDIBIOFARMA is based in the European Business and Innovation Center (CEIN) in Noáin, Navarra, where it shares a 200 m2 laboratory and performs the tasks of direction, management and medicinal chemistry.See details»
Medibiofarma SL - VentureRadar
Website: https://medibiofarma.com/ Develops innovative pharmaceutical research programs targeting cancer and neurodegenerative diseases by modulating clinically validated …See details»
Medibiofarma SL - VentureRadar
Website: https://medibiofarma.com/ Medibiofarma is a Spanish biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in …See details»
Medibiofarma SL - Drug pipelines, Patents, Clinical trials - Synapse
Medibiofarma is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry.See details»
Crohn’s & Colitis Foundation’s IBD Ventures Invests $2.4 Million in ...
Mar 21, 2023 · Medibiofarma is developing a drug that modulates the anti-fibrotic and anti-inflammatory functions of the protein PPAR gamma, which has been shown to be effective and …See details»
Medibiofarma Receives Funding from the Crohn's & Colitis …
Apr 12, 2023 · The Crohn’s & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of …See details»
Medibiofarma - Crohn's & Colitis Foundation
Medibiofarma. PPARγ partial agonist as a potential therapy for fibrosis in Crohn’s diseaseSee details»
Medibiofarma Company Profile 2024: Valuation, Funding
Developer of small molecule drugs designed to treat cancer and non-cancer diseases and offers treatments to patients suffering from conditions such as cancer, cognitive decline and fibrosis.See details»
Medibiofarma Receives Funding from the Crohn's & Colitis
Apr 11, 2023 · Medibiofarma, a biopharmaceutical company developing novel therapies for gastrointestinal diseases and other indications, announced receipt of funding from the Crohn’s …See details»
Medibiofarma - Products, Competitors, Financials, Employees ...
Medibiofarma is a clinical-stage biotechnology company focused on developing new therapies for various diseases, including neurodegenerative conditions and cancer. Use the CB Insights …See details»
Medibiofarma - Company Profile - Tracxn
Nov 19, 2024 · Medibiofarma - Developer of drugs for treating cancer. Raised a total funding of $3.32M over 2 rounds from 3 investors. Founded by Rodolfo Rodriguez Iglesias in the year …See details»
MediBiofarma - Funding, Financials, Valuation & Investors
MediBiofarma is funded by 3 investors. Inveready and SODENA are the most recent investors. in funding over 5 rounds. Their latest funding was raised on Apr 3, 2024 from a Venture - Series …See details»
Contact - Medibiofarma
Contact with the Medibiofarma team. Tell us your question and we will answer it right away, or simply find our contact information. +34 948 346 255 / [email protected]See details»
MBF-118 - Drug Targets, Indications, Patents - Synapse
MBF-118 is a patented new chemical entity that acts as a partial agonist of PPAR and has both anti-fibrotic and anti-inflammatory properties.See details»
Medibiofarma announces the closing of a new financing round of …
Mar 15, 2022 · Medibiofarma has just closed a financing round of 1.2 million euros, supported by the founder’s and other VC partners with proven experience in the field of health and …See details»
News & Events - Medibiofarma
Mar 22, 2023 · Medibiofarma Receives Funding from the Crohn’s & Colitis Foundation to Support Development of a New Antifibrotic Therapy for Inflammatory Bowel Disease; Medibiofarma …See details»